EDIT – editas medicine, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

EDIT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/15

10:33 am

edit

Editas Medicine (NASDAQ:EDIT) was upgraded by analysts at Chardan Capital from a "hold" rating to a "strong-buy" rating.

Low Report

Editas Medicine (NASDAQ:EDIT) was upgraded by analysts at Chardan Capital from a "hold" rating to a "strong-buy" rating.

Report

11/10

07:11 am

edit

Editas Medicine Announces Third Quarter 2025 Results and Business Updates [Yahoo! Finance]

Medium Report

Editas Medicine Announces Third Quarter 2025 Results and Business Updates [Yahoo! Finance]

Report

11/10

07:00 am

edit

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

Medium Report

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

Report

11/3

09:00 am

edit

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025

Low Report

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025

Report

10/24

12:21 pm

edit

Editas Medicine (NASDAQ:EDIT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Editas Medicine (NASDAQ:EDIT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.